Cabergoline for antipsychotic side effects on prolactin
Treatments studied
Part of Hormones & metabolism, Mental health clinical trials.
This trial tests if cabergoline can help reduce high prolactin levels caused by antipsychotic medications in people with schizophrenia. It may be an option if you have symptoms like breast tenderness, milk production, or sexual side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been taking antipsychotic medication for at least 3 months for schizophrenia or a related disorder.
- Your blood prolactin level is higher than normal (above the upper reference limit).
- You have symptoms of high prolactin, such as breast discharge, breast tenderness, or sexual problems, as measured on a standard side-effect scale.
- You do not have active suicidal thoughts, as shown by a low score on a suicide screening questionnaire.
- You have not tried a dopamine receptor agonist (like cabergoline) before and had a bad reaction.
- You do not use recreational drugs that could raise prolactin levels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at metabolic health (like blood sugar and cholesterol) in people with prolactinomas who are being treated with the drug cabergoline. It aims to understand how lowering prolactin affects the body's metabolism and may help guide better care for patients with this condition.
This trial compares two medications, cabergoline and bromocriptine, to see which works better for women with high prolactin levels (hyperprolactinemia). It aims to find a more effective treatment to help manage this condition, which can affect fertility and menstrual cycles.
This trial tests a higher dose of the drug cabergoline to see if it works better for small prolactin-secreting tumors (microprolactinomas) in premenopausal women who have not been treated before. It aims to find a safe and effective way to lower high prolactin levels and shrink the tumor.
This trial tests if cabergoline, a medicine, can help shrink nonfunctioning pituitary adenomas (benign tumors on the pituitary gland that don't produce excess hormones). It may be an option for people who have not had prior radiation or surgery, and whose tumors are at least 0.5 cm in size.
This study tests whether a medication called cabergoline can help stop milk production and reduce breast discomfort after a pregnancy loss or abortion.
This trial compares medicine (bromocriptine) and surgery for people with a certain type of pituitary tumor (prolactinoma) that has not spread too far. It aims to see which approach works best and is safest for you.
Hear when a new Scizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.